Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Sales (2016 - 2025)

Angiodynamics (ANGO) has disclosed Return on Sales for 16 consecutive years, with 0.08% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 7.0% year-over-year to 0.08%, compared with a TTM value of 0.09% through Nov 2025, up 69.0%, and an annual FY2025 reading of 0.12%, up 49.0% over the prior year.
  • Return on Sales was 0.08% for Q4 2025 at Angiodynamics, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.58% in Q3 2023 and bottomed at 2.5% in Q1 2024.
  • Average Return on Sales over 5 years is 0.22%, with a median of 0.11% recorded in 2021.
  • The sharpest move saw Return on Sales plummeted -238bps in 2024, then surged 244bps in 2025.
  • Year by year, Return on Sales stood at 0.11% in 2021, then grew by 7bps to 0.1% in 2022, then plummeted by -270bps to 0.37% in 2023, then surged by 60bps to 0.15% in 2024, then soared by 46bps to 0.08% in 2025.
  • Business Quant data shows Return on Sales for ANGO at 0.08% in Q4 2025, 0.14% in Q3 2025, and 0.08% in Q2 2025.